Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Economou

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Cancer Research|July 9, 1999
Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoproteinL H Butterfield, A Koh, W Meng, et al.
Cancer Gene Therapy|March 19, 2005
Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cellsJennifer A Wargo, Lana Y Schumacher, Begonya Comin-Anduix, et al.
Cancer Research|December 26, 2001
alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccinationW S Meng, L H Butterfield, A Ribas, et al.
Cancer Gene Therapy|October 19, 2002
Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccinesAntoni Ribas, Saral N Amarnani, Georgette M Buga, et al.
Anticancer Research|June 16, 1999
Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicitiesA Ribas, L A Bui, L H Butterfield, et al.
Cancer Gene Therapy|September 1, 1996
Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivityS Sharma, J Wang, M Huang, et al.
Human Gene Therapy|January 26, 2000
Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradicationP W Miller, S Sharma, M Stolina, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2001
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoproteinL H Butterfield, W S Meng, A Koh, et al.
Cancer Gene Therapy|December 23, 1999
Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cellsA Ribas, L H Butterfield, W H McBride, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assaysBegoña Comin-Anduix, Antonio Gualberto, John A Glaspy, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Cancer Research|July 9, 1999
Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoproteinL H Butterfield, A Koh, W Meng, et al.
Cancer Gene Therapy|March 19, 2005
Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cellsJennifer A Wargo, Lana Y Schumacher, Begonya Comin-Anduix, et al.
Cancer Research|December 26, 2001
alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccinationW S Meng, L H Butterfield, A Ribas, et al.
Cancer Gene Therapy|October 19, 2002
Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccinesAntoni Ribas, Saral N Amarnani, Georgette M Buga, et al.
Anticancer Research|June 16, 1999
Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicitiesA Ribas, L A Bui, L H Butterfield, et al.
Cancer Gene Therapy|September 1, 1996
Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivityS Sharma, J Wang, M Huang, et al.
Human Gene Therapy|January 26, 2000
Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradicationP W Miller, S Sharma, M Stolina, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2001
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoproteinL H Butterfield, W S Meng, A Koh, et al.
Cancer Gene Therapy|December 23, 1999
Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cellsA Ribas, L H Butterfield, W H McBride, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assaysBegoña Comin-Anduix, Antonio Gualberto, John A Glaspy, et al.
Pageof 16